Back to Results
First PageMeta Content
Health / Gilead Sciences / Sexually transmitted diseases and infections / Pre-exposure prophylaxis / Microbicides / IPrEx / Fixed dose combination / Antiretroviral drug / HIV / Medicine / HIV/AIDS / Human sexuality


CDC Fact Sheet. PrEP: A New Tool for HIV Prevention
Add to Reading List

Document Date: 2013-04-01 16:19:13


Open Document

File Size: 244,31 KB

Share Result on Facebook

City

Miami / /

Company

HIV / Gilead Sciences / /

Country

Thailand / United States / /

Event

FDA Phase / /

IndustryTerm

HIV treatment / reduction support services / prevention services / HIV Prevention / tenofovir-plus-emtricitabine / other HIV prevention / HIV care / treatment of hepatitis B / prevention tool / /

MedicalCondition

HIV infection / active infection / epidemic / malaria / sexually-acquired HIV infection / permanent infection / acute HIV infection / active hepatitis B / hepatitis B / HIV infections / diseases / sexually transmitted infections / infection / /

MedicalTreatment

antiretroviral therapy / counseling / /

Organization

U.S. Public Health Service / U.S. Food and Drug Administration / U.S. Department of Health and Human Services Centers for Disease Control and Prevention / Federal Trade Commission / /

Product

tenofovir disoproxil fumarate / Truvada / Planned PrEP Trials Injection / PrEP medication / Truvada® / PrEP / /

ProvinceOrState

California / /

URL

www.avac.org / /

SocialTag